| Demographic Characteristic | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 12 or Older | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| TOTAL | 3,456a | 2,939 | 1.2b | 1.0 | 2.3a | 1.9 | 5.6b | 4.6 |
| AGE GROUP | ||||||||
| 12-20 | 1,800a | 1,490 | 4.7b | 3.9 | 5.7b | 4.7 | 25.7 | 23.2 |
| 21 or Older | 1,656 | 1,449 | 0.7 | 0.6 | 1.4 | 1.2 | 3.0 | 2.5 |
| 12-25 | 2,364b | 1,935 | 3.9b | 3.2 | 5.7b | 4.6 | 15.4b | 13.0 |
| 12-17 | 1,169b | 912 | 4.5b | 3.5 | 4.9a | 3.9 | 40.4a | 33.8 |
| 12-13 | 102 | 122 | 1.3 | 1.5 | 1.3 | 1.5 | 65.8 | * |
| 14-15 | 500b | 255 | 5.5b | 2.9 | 5.9b | 3.1 | 48.3b | 34.6 |
| 16-17 | 567 | 534 | 6.4 | 5.9 | 7.7 | 7.3 | 33.3 | 30.2 |
| 18 or Older | 2,287 | 2,027 | 0.9 | 0.8 | 1.8 | 1.6 | 3.9 | 3.3 |
| 18-25 | 1,195 | 1,023 | 3.5 | 2.9 | 6.6 | 5.4 | 9.6 | 8.4 |
| 18-20 | 631 | 579 | 5.2 | 4.6 | 8.1 | 7.0 | 15.4 | 15.5 |
| 21-25 | 563 | 444 | 2.6 | 2.0 | 5.4 | 4.2 | 6.8 | 5.2 |
| 26 or Older | 1,092 | 1,004 | 0.5 | 0.4 | 1.0 | 0.9 | 2.3 | 2.0 |
| SEX | ||||||||
| Male | 1,479 | 1,312 | 1.1 | 0.9 | 2.1 | 1.8 | 4.5 | 3.8 |
| Female | 1,977a | 1,627 | 1.4a | 1.1 | 2.4a | 2.0 | 6.9a | 5.5 |
| SEX/AGE GROUP | ||||||||
| Male 12-17 | 605a | 432 | 4.6a | 3.3 | 4.9a | 3.6 | 46.9b | 34.9 |
| Female 12-17 | 564 | 479 | 4.5 | 3.8 | 5.0 | 4.2 | 35.2 | 33.0 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Demographic Characteristic | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 12 or Older | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| TOTAL | 1,499 | 1,481 | 0.5 | 0.5 | 1.1 | 1.0 | 3.1 | 3.1 |
| AGE GROUP | ||||||||
| 12-201 | 887 | 860 | 2.3 | 2.2 | 2.6 | 2.5 | 33.9 | 33.6 |
| 21 or Older1 | 612 | 621 | 0.2 | 0.2 | 0.6 | 0.6 | 1.3 | 1.4 |
| 12-25 | 1,396 | 1,344 | 2.3 | 2.2 | 2.9 | 2.8 | 19.3 | 19.2 |
| 12-17 | 452 | 342 | 1.7 | 1.3 | 1.8 | 1.4 | 50.5 | 42.6 |
| 12-13 | 57 | 47 | 0.7 | 0.6 | 0.7 | 0.6 | * | * |
| 14-15 | 146 | 114 | 1.6 | 1.3 | 1.7 | 1.3 | * | 47.2 |
| 16-17 | 248 | 181 | 2.8 | 2.0 | 3.0 | 2.2 | 49.0 | 38.7 |
| 18 or Older | 1,047 | 1,139 | 0.4 | 0.4 | 0.9 | 1.0 | 2.2 | 2.5 |
| 18-25 | 945 | 1,002 | 2.8 | 2.9 | 4.1 | 4.1 | 14.9 | 16.2 |
| 18-20 | 435 | 518 | 3.6 | 4.1 | 4.5 | 5.1 | 25.3 | 29.5 |
| 21-25 | 510 | 484 | 2.3 | 2.2 | 3.8 | 3.5 | 11.1 | 10.9 |
| 26 or Older | 103 | 138 | <0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 |
| SEX | ||||||||
| Male | 784 | 724 | 0.6 | 0.5 | 1.3 | 1.1 | 2.9 | 2.7 |
| Female | 715 | 757 | 0.5 | 0.5 | 0.9 | 1.0 | 3.3 | 3.7 |
| SEX/AGE GROUP | ||||||||
| Male 12-17 | 212 | 151 | 1.6 | 1.1 | 1.7 | 1.2 | 52.3 | 40.8 |
| Female 12-17 | 239 | 191 | 1.9 | 1.5 | 2.0 | 1.6 | 49.0 | 44.2 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The 12-20 and 21 or older rows are included because they are the underage and legal age groups for tobacco. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Demographic Characteristic | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 12 or Older | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| TOTAL | 5,942 | 5,362 | 2.1a | 1.9 | 2.7 | 2.4 | 15.7b | 13.5 |
| AGE GROUP | ||||||||
| 12-201 | 2,153a | 1,801 | 5.7a | 4.7 | 7.2a | 6.0 | 29.2 | 26.2 |
| 21 or Older1 | 3,790 | 3,560 | 1.5 | 1.4 | 2.0 | 1.9 | 12.4 | 10.9 |
| 12-25 | 2,836b | 2,299 | 4.7b | 3.8 | 6.9b | 5.6 | 18.9b | 15.7 |
| 12-17 | 1,467b | 1,144 | 5.7b | 4.4 | 6.5b | 5.1 | 42.9b | 35.7 |
| 12-13 | 294a | 195 | 3.7a | 2.4 | 3.8a | 2.5 | 68.3b | 49.4 |
| 14-15 | 591a | 428 | 6.5a | 4.8 | 7.5a | 5.5 | 45.5 | 41.1 |
| 16-17 | 582 | 522 | 6.6 | 5.8 | 8.4 | 7.6 | 34.5 | 29.5 |
| 18 or Older | 4,475 | 4,217 | 1.7 | 1.6 | 2.3 | 2.1 | 13.0 | 11.6 |
| 18-25 | 1,369 | 1,154 | 4.0a | 3.3 | 7.5a | 6.2 | 11.8 | 10.1 |
| 18-20 | 685 | 657 | 5.6 | 5.2 | 9.1 | 8.4 | 17.4 | 17.9 |
| 21-25 | 684a | 497 | 3.1b | 2.2 | 6.3a | 4.6 | 9.0b | 6.4 |
| 26 or Older | 3,106 | 3,063 | 1.4 | 1.3 | 1.7 | 1.7 | 13.5 | 12.3 |
| SEX | ||||||||
| Male | 2,515 | 2,507 | 1.8 | 1.8 | 2.4 | 2.4 | 12.8 | 12.1 |
| Female | 3,427a | 2,855 | 2.4b | 1.9 | 3.0a | 2.5 | 18.7b | 15.2 |
| SEX/AGE GROUP | ||||||||
| Male 12-17 | 663 | 559 | 5.0 | 4.2 | 5.6 | 4.8 | 46.8 | 40.0 |
| Female 12-17 | 805b | 585 | 6.4b | 4.6 | 7.5b | 5.5 | 40.1a | 32.4 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The 12-20 and 21 or older rows are included because they are the underage and legal age groups for tobacco. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Demographic Characteristic | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 12 or Older | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| TOTAL | 4,214 | 4,218 | 1.5 | 1.5 | 6.6 | 6.6 | 2.4 | 2.4 |
| AGE GROUP | ||||||||
| 12-201 | 3,013 | 2,872 | 7.9 | 7.5 | 10.6 | 10.0 | 28.4 | 27.6 |
| 21 or Older1 | 1,201 | 1,346 | 0.5 | 0.5 | 3.4 | 3.8 | 0.7 | 0.8 |
| 12-25 | 4,105 | 4,008 | 6.8 | 6.6 | 12.4 | 11.9 | 14.9 | 14.5 |
| 12-17 | 1,821 | 1,651 | 7.0 | 6.4 | 8.2 | 7.5 | 41.5 | 38.9 |
| 12-13 | 215 | 207 | 2.7 | 2.6 | 2.9 | 2.7 | 59.7 | 56.2 |
| 14-15 | 661a | 498 | 7.2a | 5.6 | 8.3a | 6.4 | 46.2 | 42.8 |
| 16-17 | 945 | 947 | 10.7 | 10.5 | 14.2 | 14.4 | 36.4 | 34.9 |
| 18 or Older | 2,393 | 2,567 | 0.9 | 1.0 | 5.8 | 6.1 | 1.4 | 1.5 |
| 18-25 | 2,284 | 2,356 | 6.7 | 6.7 | 21.0 | 20.5 | 9.9 | 10.1 |
| 18-20 | 1,192 | 1,221 | 9.8 | 9.7 | 18.9 | 18.3 | 19.2 | 19.8 |
| 21-25 | 1,092 | 1,136 | 5.0 | 5.1 | 23.9 | 23.5 | 6.4 | 6.6 |
| 26 or Older | 109 | 210 | <0.1 | 0.1 | 0.4 | 0.7 | 0.1 | 0.1 |
| SEX | ||||||||
| Male | 2,119 | 2,179 | 1.5 | 1.5 | 7.2 | 7.4 | 2.4 | 2.5 |
| Female | 2,094 | 2,039 | 1.4 | 1.4 | 6.2 | 5.9 | 2.4 | 2.3 |
| SEX/AGE GROUP | ||||||||
| Male 12-17 | 818 | 755 | 6.2 | 5.7 | 7.1 | 6.6 | 41.9 | 38.9 |
| Female 12-17 | 1,003 | 896 | 7.9 | 7.1 | 9.5 | 8.4 | 41.2 | 38.9 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Substance | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 12 or Older | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| ILLICIT DRUGS | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 3,456a | 2,939 | 1.2b | 1.0 | 2.3a | 1.9 | 5.6b | 4.6 |
| Cocaine | 470 | 426 | 0.2 | 0.1 | 0.2 | 0.2 | 9.4 | 10.0 |
| Crack | 79 | 63 | <0.1 | <0.1 | <0.1 | <0.1 | 7.9 | 8.4 |
| Heroin | 28 | 30 | <0.1 | <0.1 | <0.1 | <0.1 | 4.2 | 5.4 |
| Hallucinogens | 1,510 | 1,632 | 0.5 | 0.6 | 0.6 | 0.7 | 17.2 | 15.7 |
| LSD | 364 | 293 | 0.1 | 0.1 | 0.1 | 0.1 | 21.5 | 18.1 |
| PCP | 24 | 39 | <0.1 | <0.1 | <0.1 | <0.1 | * | * |
| Ecstasy | 507 | 377 | 0.2 | 0.1 | 0.2 | 0.1 | 23.5 | 18.7 |
| Inhalants | -- | 688 | -- | 0.2 | -- | 0.3 | -- | 21.8 |
| Methamphetamine | 78 | 104 | <0.1 | <0.1 | <0.1 | <0.1 | 3.0 | 4.4 |
| Misuse of Prescription Psychotherapeutics | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers | 1,380 | 1,522 | 0.5 | 0.5 | nr | nr | 16.1 | 19.0 |
| Stimulants | 712 | 619 | 0.3 | 0.2 | nr | nr | 18.2 | 15.9 |
| Tranquilizers or Sedatives | nr | nr | nr | nr | nr | nr | nr | nr |
| Tranquilizers | 530 | 704 | 0.2 | 0.2 | nr | nr | 13.3 | 18.4 |
| Sedatives | 252 | 205 | 0.1 | 0.1 | nr | nr | 23.7 | 22.3 |
| Benzodiazepines | -- | -- | -- | -- | -- | -- | -- | -- |
| Opioids | -- | -- | -- | -- | -- | -- | -- | -- |
| Illicit Drugs Other Than Marijuana1 | nr | nr | nr | nr | nr | nr | nr | nr |
| TOBACCO PRODUCT USE OR NICOTINE VAPING2 | nr | nr | nr | nr | nr | nr | nr | nr |
| Cigarettes | 1,499 | 1,481 | 0.5 | 0.5 | 1.1 | 1.0 | 3.1 | 3.1 |
| Daily Cigarettes | 322 | 237 | 0.1 | 0.1 | 0.2 | 0.1 | -- | -- |
| Smokeless Tobacco | 860 | 1,059 | 0.3 | 0.4 | 0.3 | 0.4 | 9.1 | 11.4 |
| Cigars | 1,984a | 1,560 | 0.7a | 0.5 | 1.0a | 0.8 | 10.0 | 8.5 |
| Nicotine Vaping | 5,942 | 5,362 | 2.1a | 1.9 | 2.7 | 2.4 | 15.7b | 13.5 |
| ALCOHOL | 4,214 | 4,218 | 1.5 | 1.5 | 6.6 | 6.6 | 2.4 | 2.4 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 2 Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products or nicotine vaping measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Substance | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 12 to 17 | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| ILLICIT DRUGS | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,169b | 912 | 4.5b | 3.5 | 4.9a | 3.9 | 40.4a | 33.8 |
| Cocaine | 23 | 33 | 0.1 | 0.1 | 0.1 | 0.1 | * | * |
| Crack | 4 | 6 | <0.1 | <0.1 | <0.1 | <0.1 | * | * |
| Heroin | 4 | 10 | <0.1 | <0.1 | <0.1 | <0.1 | * | * |
| Hallucinogens | 248 | 238 | 1.0 | 0.9 | 1.0 | 0.9 | 64.0 | 58.6 |
| LSD | 101 | 88 | 0.4 | 0.3 | 0.4 | 0.3 | * | * |
| PCP | 8 | 1 | <0.1 | <0.1 | <0.1 | <0.1 | * | * |
| Ecstasy | 61a | 26 | 0.2a | 0.1 | 0.2a | 0.1 | * | * |
| Inhalants | -- | 264 | -- | 1.0 | -- | 1.1 | -- | 27.3 |
| Methamphetamine | 15 | 14 | 0.1 | 0.1 | 0.1 | 0.1 | * | * |
| Misuse of Prescription Psychotherapeutics | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers | 210 | 153 | 0.8 | 0.6 | nr | nr | 36.8 | 36.2 |
| Stimulants | 91 | 61 | 0.4 | 0.2 | nr | nr | * | * |
| Tranquilizers or Sedatives | nr | nr | nr | nr | nr | nr | nr | nr |
| Tranquilizers | 42 | 56 | 0.2 | 0.2 | nr | nr | * | * |
| Sedatives | 41 | 14 | 0.2 | 0.1 | nr | nr | * | * |
| Benzodiazepines | -- | -- | -- | -- | -- | -- | -- | -- |
| Opioids | -- | -- | -- | -- | -- | -- | -- | -- |
| Illicit Drugs Other Than Marijuana1 | nr | nr | nr | nr | nr | nr | nr | nr |
| TOBACCO PRODUCT USE OR NICOTINE VAPING2 | nr | nr | nr | nr | nr | nr | nr | nr |
| Cigarettes | 452 | 342 | 1.7 | 1.3 | 1.8 | 1.4 | 50.5 | 42.6 |
| Daily Cigarettes | 22 | 35 | 0.1 | 0.1 | 0.1 | 0.1 | -- | -- |
| Smokeless Tobacco | 109 | 171 | 0.4 | 0.7 | 0.4 | 0.7 | * | 60.6 |
| Cigars | 245 | 224 | 0.9 | 0.9 | 1.0 | 0.9 | 61.0 | 48.3 |
| Nicotine Vaping | 1,467b | 1,144 | 5.7b | 4.4 | 6.5b | 5.1 | 42.9b | 35.7 |
| ALCOHOL | 1,821 | 1,651 | 7.0 | 6.4 | 8.2 | 7.5 | 41.5 | 38.9 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 2 Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products or nicotine vaping measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Substance | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 18 or Older | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| ILLICIT DRUGS | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 2,287 | 2,027 | 0.9 | 0.8 | 1.8 | 1.6 | 3.9 | 3.3 |
| Cocaine | 447 | 393 | 0.2 | 0.1 | 0.2 | 0.2 | 9.0 | 9.4 |
| Crack | 75 | 57 | <0.1 | <0.1 | <0.1 | <0.1 | 7.5 | 7.6 |
| Heroin | 24 | 20 | <0.1 | <0.1 | <0.1 | <0.1 | 3.6 | 3.7 |
| Hallucinogens | 1,262 | 1,394 | 0.5 | 0.5 | 0.6 | 0.7 | 15.0 | 13.9 |
| LSD | 263 | 205 | 0.1 | 0.1 | 0.1 | 0.1 | 16.9 | 13.6 |
| PCP | 16 | 39 | <0.1 | <0.1 | <0.1 | <0.1 | * | * |
| Ecstasy | 446 | 351 | 0.2 | 0.1 | 0.2 | 0.1 | 21.5 | 18.0 |
| Inhalants | -- | 424 | -- | 0.2 | -- | 0.2 | -- | 19.4 |
| Methamphetamine | 64 | 89 | <0.1 | <0.1 | <0.1 | <0.1 | 2.5 | 3.8 |
| Misuse of Prescription Psychotherapeutics | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers | 1,170 | 1,368 | 0.5 | 0.5 | nr | nr | 14.6 | 18.1 |
| Stimulants | 621 | 558 | 0.2 | 0.2 | nr | nr | 16.8 | 15.1 |
| Tranquilizers or Sedatives | nr | nr | nr | nr | nr | nr | nr | nr |
| Tranquilizers | 488 | 648 | 0.2 | 0.2 | nr | nr | 12.6 | 17.5 |
| Sedatives | 211 | 192 | 0.1 | 0.1 | nr | nr | * | 22.4 |
| Benzodiazepines | -- | -- | -- | -- | -- | -- | -- | -- |
| Opioids | -- | -- | -- | -- | -- | -- | -- | -- |
| Illicit Drugs Other Than Marijuana1 | nr | nr | nr | nr | nr | nr | nr | nr |
| TOBACCO PRODUCT USE OR NICOTINE VAPING2 | nr | nr | nr | nr | nr | nr | nr | nr |
| Cigarettes | 1,047 | 1,139 | 0.4 | 0.4 | 0.9 | 1.0 | 2.2 | 2.5 |
| Daily Cigarettes | 301 | 202 | 0.1 | 0.1 | 0.2 | 0.1 | -- | -- |
| Smokeless Tobacco | 751 | 888 | 0.3 | 0.3 | 0.3 | 0.4 | 8.1 | 9.9 |
| Cigars | 1,739a | 1,336 | 0.7a | 0.5 | 1.0a | 0.7 | 8.9 | 7.5 |
| Nicotine Vaping | 4,475 | 4,217 | 1.7 | 1.6 | 2.3 | 2.1 | 13.0 | 11.6 |
| ALCOHOL | 2,393 | 2,567 | 0.9 | 1.0 | 5.8 | 6.1 | 1.4 | 1.5 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 2 Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products or nicotine vaping measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Substance | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 18 to 25 | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| ILLICIT DRUGS | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,195 | 1,023 | 3.5 | 2.9 | 6.6 | 5.4 | 9.6 | 8.4 |
| Cocaine | 260 | 273 | 0.8 | 0.8 | 0.8 | 0.8 | 24.9 | 33.6 |
| Crack | 32 | 8 | 0.1 | <0.1 | 0.1 | <0.1 | * | * |
| Heroin | 7 | 20 | <0.1 | 0.1 | <0.1 | 0.1 | * | * |
| Hallucinogens | 635 | 582 | 1.9 | 1.7 | 2.2 | 1.9 | 27.9 | 24.6 |
| LSD | 143 | 116 | 0.4 | 0.3 | 0.5 | 0.4 | 28.4 | 31.5 |
| PCP | * | 5 | * | <0.1 | * | <0.1 | * | * |
| Ecstasy | 233 | 146 | 0.7 | 0.4 | 0.7 | 0.4 | 44.8 | 36.2 |
| Inhalants | -- | 283 | -- | 0.8 | -- | 0.9 | -- | 41.0 |
| Methamphetamine | 13 | 23 | <0.1 | 0.1 | <0.1 | 0.1 | 12.5 | * |
| Misuse of Prescription Psychotherapeutics | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers | 191 | 241 | 0.6 | 0.7 | nr | nr | 22.7 | 25.2 |
| Stimulants | 277 | 244 | 0.8 | 0.7 | nr | nr | 25.9 | 25.1 |
| Tranquilizers or Sedatives | nr | nr | nr | nr | nr | nr | nr | nr |
| Tranquilizers | 123 | 110 | 0.4 | 0.3 | nr | nr | 23.5 | 21.2 |
| Sedatives | 23 | 14 | 0.1 | <0.1 | nr | nr | * | * |
| Benzodiazepines | -- | -- | -- | -- | -- | -- | -- | -- |
| Opioids | -- | -- | -- | -- | -- | -- | -- | -- |
| Illicit Drugs Other Than Marijuana1 | nr | nr | nr | nr | nr | nr | nr | nr |
| TOBACCO PRODUCT USE OR NICOTINE VAPING2 | nr | nr | nr | nr | nr | nr | nr | nr |
| Cigarettes | 945 | 1,002 | 2.8 | 2.9 | 4.1 | 4.1 | 14.9 | 16.2 |
| Daily Cigarettes | 198 | 161 | 0.6 | 0.5 | 0.6 | 0.5 | -- | -- |
| Smokeless Tobacco | 473 | 502 | 1.4 | 1.4 | 1.5 | 1.6 | 30.0 | 25.8 |
| Cigars | 1,065 | 867 | 3.1a | 2.5 | 3.9a | 3.0 | 27.0 | 22.9 |
| Nicotine Vaping | 1,369 | 1,154 | 4.0a | 3.3 | 7.5a | 6.2 | 11.8 | 10.1 |
| ALCOHOL | 2,284 | 2,356 | 6.7 | 6.7 | 21.0 | 20.5 | 9.9 | 10.1 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 2 Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products or nicotine vaping measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Substance | Number of Past Year Initiates (1,000s) | Percentage of Past Year Initiates among People Aged 26 or Older | Percentage of Past Year Initiates among People at Risk for Initiation | Percentage of Past Year Initiates among Past Year Users | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| ILLICIT DRUGS | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,092 | 1,004 | 0.5 | 0.4 | 1.0 | 0.9 | 2.3 | 2.0 |
| Cocaine | 187 | 120 | 0.1 | 0.1 | 0.1 | 0.1 | 4.8 | 3.6 |
| Crack | 42 | 49 | <0.1 | <0.1 | <0.1 | <0.1 | 4.6 | 7.0 |
| Heroin | 17 | * | <0.1 | * | <0.1 | * | 2.7 | * |
| Hallucinogens | 627 | 812 | 0.3 | 0.4 | 0.3 | 0.4 | 10.2 | 10.6 |
| LSD | 120 | 88 | 0.1 | <0.1 | 0.1 | <0.1 | 11.4 | 7.8 |
| PCP | 16 | 34 | <0.1 | <0.1 | <0.1 | <0.1 | * | * |
| Ecstasy | 213 | 205 | 0.1 | 0.1 | 0.1 | 0.1 | 13.7 | 13.2 |
| Inhalants | -- | 141 | -- | 0.1 | -- | 0.1 | -- | 9.4 |
| Methamphetamine | 50 | 66 | <0.1 | <0.1 | <0.1 | <0.1 | 2.0 | 3.0 |
| Misuse of Prescription Psychotherapeutics | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers | 979 | 1,127 | 0.4 | 0.5 | nr | nr | 13.7 | 17.0 |
| Stimulants | 344 | 313 | 0.2 | 0.1 | nr | nr | 13.1 | 11.5 |
| Tranquilizers or Sedatives | nr | nr | nr | nr | nr | nr | nr | nr |
| Tranquilizers | 366 | 538 | 0.2 | 0.2 | nr | nr | 10.9a | 16.9 |
| Sedatives | 188 | 178 | 0.1 | 0.1 | nr | nr | * | 22.8 |
| Benzodiazepines | -- | -- | -- | -- | -- | -- | -- | -- |
| Opioids | -- | -- | -- | -- | -- | -- | -- | -- |
| Illicit Drugs Other Than Marijuana1 | nr | nr | nr | nr | nr | nr | nr | nr |
| TOBACCO PRODUCT USE OR NICOTINE VAPING2 | nr | nr | nr | nr | nr | nr | nr | nr |
| Cigarettes | 103 | 138 | <0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 |
| Daily Cigarettes | 102 | 41 | <0.1 | <0.1 | 0.1 | <0.1 | -- | -- |
| Smokeless Tobacco | 278 | 386 | 0.1 | 0.2 | 0.1 | 0.2 | 3.6 | 5.5 |
| Cigars | 674 | 469 | 0.3 | 0.2 | 0.5 | 0.3 | 4.3 | 3.3 |
| Nicotine Vaping | 3,106 | 3,063 | 1.4 | 1.3 | 1.7 | 1.7 | 13.5 | 12.3 |
| ALCOHOL | 109 | 210 | <0.1 | 0.1 | 0.4 | 0.7 | 0.1 | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 2 Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products or nicotine vaping measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
| Substance | People Who Initiated Use Prior to Age 18 | People Who Initiated Use Prior to Age 211 | People Who Initiated Use at Age 21 or Older1 | |||
|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| ILLICIT DRUGS | nr | nr | nr | nr | nr | nr |
| Marijuana | 1,294b | 998 | 1,882b | 1,531 | 1,574 | 1,408 |
| Cocaine | 24 | 34 | 153 | 134 | 317 | 292 |
| Crack | 4 | 6 | 31 | 9 | 48 | 54 |
| Heroin | * | 10 | 9 | 18 | 19 | 12 |
| Hallucinogens | 276 | 259 | 572 | 532 | 937 | 1,100 |
| LSD | 112 | 90 | 168 | 143 | 196 | 150 |
| PCP | 8 | 1 | 8 | 3 | 16 | 36 |
| Ecstasy | 75b | 26 | 172a | 83 | 335 | 293 |
| Inhalants | -- | 282 | -- | 404 | -- | 284 |
| Methamphetamine | 20 | 14 | 24 | 15 | 55 | 88 |
| Misuse of Prescription Psychotherapeutics | nr | nr | nr | nr | nr | nr |
| Pain Relievers | 220 | 173 | 277 | 275 | 1,103 | 1,247 |
| Stimulants | 95 | * | 201 | 177 | 512 | 442 |
| Tranquilizers or Sedatives | nr | nr | nr | nr | nr | nr |
| Tranquilizers | * | * | 78 | * | 452 | 583 |
| Sedatives | * | * | * | * | 196 | 180 |
| Benzodiazepines | -- | -- | -- | -- | -- | -- |
| Opioids | -- | -- | -- | -- | -- | -- |
| Illicit Drugs Other Than Marijuana2 | nr | nr | nr | nr | nr | nr |
| TOBACCO PRODUCT USE OR NICOTINE VAPING3 | nr | nr | nr | nr | nr | nr |
| Cigarettes | 489 | 399 | 971 | 950 | 528 | 531 |
| Daily Cigarettes | 35 | 35 | 131 | 106 | 192 | 131 |
| Smokeless Tobacco | 154 | 187 | 351 | 428 | 509 | 631 |
| Cigars | 306 | 270 | 779 | 629 | 1,204 | 931 |
| Nicotine Vaping | 1,567a | 1,296 | 2,229a | 1,850 | 3,713 | 3,512 |
| ALCOHOL | 1,957 | 1,786 | 3,093 | 2,983 | 1,121 | 1,235 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The prior to 21 and 21 or older columns are included because they are the underage and legal age groups for tobacco and alcohol. 2 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products or nicotine vaping measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||
| Substance | Number of Past Year Initiates (1,000s) | Mean Age among Past Year Initiates | Mean Age among Past Year Male Initiates | Mean Age among Past Year Female Initiates | ||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | |
| ILLICIT DRUGS | nr | nr | nr | nr | nr | nr | nr | nr |
| Marijuana | 2,963b | 2,501 | 21.0 | 21.7 | 19.8 | 20.5 | 22.1 | 22.7 |
| Cocaine | 454 | 409 | 24.8a | 22.6 | 24.4 | 23.6 | 25.2b | 21.4 |
| Crack | 66 | 63 | 27.2 | 30.6 | * | * | 31.6 | 31.9 |
| Heroin | 28 | 30 | 29.1a | 18.3 | * | * | * | 17.1 |
| Hallucinogens | 1,443 | 1,486 | 25.1 | 26.0 | 24.2 | 25.1 | 26.2 | 27.0 |
| LSD | 356 | 277 | 22.8 | 23.0 | 21.3 | 22.2 | 24.3 | 23.7 |
| PCP | 24 | 23 | * | * | * | * | * | * |
| Ecstasy | 460 | 357 | 24.8 | 27.2 | 23.1 | 26.6 | 26.7 | 27.9 |
| Inhalants | -- | 676 | -- | 20.1 | -- | 18.8 | -- | 21.3 |
| Methamphetamine | 59 | 99 | 25.4 | 31.5 | 22.5 | 32.2 | 26.5 | 29.7 |
| Misuse of Prescription Psychotherapeutics | nr | nr | nr | nr | nr | nr | nr | nr |
| Pain Relievers | 899 | 922 | 27.8 | 29.2 | 29.0 | 30.1 | 26.6 | 28.5 |
| Stimulants | 656 | 580 | 25.1 | 27.3 | 25.0 | 27.6 | 25.2 | 27.1 |
| Tranquilizers or Sedatives | nr | nr | nr | nr | nr | nr | nr | nr |
| Tranquilizers | 411 | 449 | 30.1 | 29.9 | 30.6 | 33.1 | 29.9 | 26.7 |
| Sedatives | 149 | 132 | 27.4 | 33.3 | 28.3 | 34.5 | 23.9 | 32.3 |
| Benzodiazepines | -- | -- | -- | -- | -- | -- | -- | -- |
| Opioids | -- | -- | -- | -- | -- | -- | -- | -- |
| Illicit Drugs Other Than Marijuana1 | nr | nr | nr | nr | nr | nr | nr | nr |
| TOBACCO PRODUCT USE OR NICOTINE VAPING2 | nr | nr | nr | nr | nr | nr | nr | nr |
| Cigarettes | 1,499 | 1,451 | 19.5 | 19.9 | 19.5 | 19.3 | 19.4 | 20.5 |
| Daily Cigarettes | 290 | 237 | 22.3 | 22.1 | 21.8 | 21.2 | 23.6 | 23.4 |
| Smokeless Tobacco | 809a | 1,051 | 23.6 | 24.2 | 23.1 | 24.0 | 24.7 | 24.7 |
| Cigars | 1,733 | 1,460 | 22.6 | 23.2 | 22.0 | 21.7 | 24.1 | 25.4 |
| Nicotine Vaping | 5,074b | 4,299 | 25.3 | 26.0 | 24.0 | 25.6 | 26.3 | 26.4 |
| ALCOHOL | 4,208 | 4,209 | 18.0a | 18.6 | 18.2 | 18.8 | 17.7 | 18.4 |
| * = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 2 Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products or nicotine vaping measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024. |
||||||||
